ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 95 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,870,915 | +62.2% | 541,920 | +128.1% | 0.01% | +50.0% |
| Q2 2023 | $6,703,260 | +1324654.9% | 237,620 | +708.4% | 0.00% | – |
| Q1 2023 | $506 | -21.9% | 29,394 | -8.7% | 0.00% | – |
| Q4 2022 | $648 | -100.0% | 32,186 | -68.0% | 0.00% | -100.0% |
| Q3 2022 | $2,181,000 | +57.6% | 100,672 | +235.6% | 0.00% | 0.0% |
| Q1 2022 | $1,384,000 | -67.7% | 30,000 | -41.1% | 0.00% | -66.7% |
| Q4 2021 | $4,284,000 | +205.3% | 50,966 | +93.3% | 0.00% | +200.0% |
| Q2 2021 | $1,403,000 | -74.8% | 26,368 | -79.4% | 0.00% | -75.0% |
| Q1 2021 | $5,564,000 | – | 128,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |